The Effectiveness of second-and-third line biologics in perianal Crohn's disease - a multicenter propensity score-matched study - Articles - Gastroenterology

Inflammatory Bowel Disease

Evaluation of Crohn's Disease Activity: Validation of a Segmental Simple Ultrasound Score in a Multicenter Study

Inflamm Bowel Dis

Ripollés T, Poza J, Martínez-Pérez MJ, Suarez Ferrer C, Blanc E, Paredes JM

doi: 10.1093/ibd/izae213

Further Publications

Early tumour necrosis factor antagonist treatment prevents perianal fistula development in children with Crohn's disease: post hoc analysis of the RISK study

Gut

Adler J, Gadepalli S, Rahman M, Kim S

doi: 10.1136/gutjnl-2024-333280

Further Publications

Adverse maternal outcomes after vaginal versus caesarean delivery in women with Crohn's disease and prior perianal surgery: A population-based study

J Crohns Colitis

Zhang X, Nørgård BM, Garvik OS, Nielsen J, Andersen ML, Friedman S

doi: 10.1093/ecco-jcc/jjaf028

Inflammatory Bowel Disease

Biologic switch timing and risk of infection in patients with ulcerative colitis/Crohn's disease: a retrospective study

Clin Gastroenterol Hepatol

Kruger AJ, Dormont F, Capit N, Schilsky S, Roberts A, Lin Y, Badalamenti S, Wiekowski M, Bewtra M, Colombel JF

doi: 10.1016/j.cgh.2025.01.028

Inflammatory Bowel Disease

Real-World Effectiveness and Safety of Upadacitinib in Crohn's disease: A Multi-Centre Study

Clin Gastroenterol Hepatol

Devi J, Xu A, Stone M, Patel A, Khan A, Reddy N, Klein J, Chowla N, Benson C, Luu BC, Huang K, Jaiprada F, Fenster M, Ungaro R, Pekow J, Johnson AM, Yarur AJ, Shukla R, Huecker J, Bishu S, REBOOT IBD consortium, Deepak P

doi: 10.1016/j.cgh.2025.01.012

Inflammatory Bowel Disease

Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn's Disease and Ulcerative Colitis

J Crohns Colitis

D'Haens G, Danese S, Panaccione R, Rubin DT, Peyrin-Biroulet L, Matsuoka K, Loftus EV Jr, Kobayashi T, Elsharkawi W, Miceli R, Ahmed S, Luo Y, Napoli A, Vaile J, Dornic Q, Patel A, Schreiber S

doi: 10.1093/ecco-jcc/jjaf080

Further Publications

Perianal Disease in Pediatric-Onset Crohn's Disease: Incidence, Disease Course, and Long-Term Outcomes

Clin Gastroenterol Hepatol

Ström A, Jansson S, Wewer MD, Burisch J, Malham M, Wewer V

doi: 10.1016/j.cgh.2025.05.015

Inflammatory Bowel Disease

Predictive modeling to evaluate long-term treatment effectiveness of darvadstrocel in patients with complex perianal fistulas in Crohn's disease

BMC Gastroenterol

Karki C, Hantsbarger G, Turkstra E, Fenu E, Genenz K, Gilaberte I, Panés J

doi: 10.1186/s12876-024-03513-3

Inflammatory Bowel Disease

Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease Patients

Inflamm Bowel Dis

Gebeyehu GG, Broglio G, Liu E, Limdi JK, Selinger C, Fiske J, Razanskaite V, Smith PJ, Flanagan PK, Subramanian S

doi: 10.1093/ibd/izae174

Related content

Evaluation of Crohn's Disease Activity: Validation of a Segmental Simple Ultrasound Score in a Multicenter Study

Early tumour necrosis factor antagonist treatment prevents perianal fistula development in children with Crohn's disease: post hoc analysis of the RISK study

Adverse maternal outcomes after vaginal versus caesarean delivery in women with Crohn's disease and prior perianal surgery: A population-based study

Biologic switch timing and risk of infection in patients with ulcerative colitis/Crohn's disease: a retrospective study

Real-World Effectiveness and Safety of Upadacitinib in Crohn's disease: A Multi-Centre Study

Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn's Disease and Ulcerative Colitis

Perianal Disease in Pediatric-Onset Crohn's Disease: Incidence, Disease Course, and Long-Term Outcomes

Predictive modeling to evaluate long-term treatment effectiveness of darvadstrocel in patients with complex perianal fistulas in Crohn's disease

Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease Patients